Matthew McFarland, RPh, PhD, has joined Nationwide Children’s as the director of the Office of Technology Commercialization. As director, he works closely with Nationwide Children’s faculty and staff to identify intellectual property with commercial potential and to facilitate the transfer of new technologies to outside partners, ultimately for the benefit and enhancement of pediatric care. He has a diverse background in technology transfer, technology valuation and licensing, academic research and pharmacy practice.
Prior to joining Nationwide Children’s, Dr. McFarland was the associate director of commercialization, innovation strategy manager and technology manager in the Office of Technology Commercialization at the Purdue Research Foundation.
He received a Bachelor of Science degree in pharmacy from Ohio Northern University and his PhD in medicinal chemistry and molecular pharmacology from Purdue University. He also completed a post-doctoral research fellowship in translational genetics and pharmacogenomics of neuropsychiatric disorders at the Institute of Psychiatric Research, Indiana University Medical School.
Dr. McFarland has authored several articles for peer-reviewed journals including Molecular Pharmacology, Journal of Biological Chemistry and Medical Innovation & Business. He also has received the Jenkins/Knevel Award for Excellence in Research and the Albert and Anna Kienley Award for Excellence in Teaching from the School of Pharmacy at Purdue University.